From validation trials to clinical reality: implementing AI-supported prostate MRI pathways in the NHS.
Authors
Affiliations (3)
Affiliations (3)
- Clinical Fellow, AI and Research, Department of Clinical Informatics, George Eliot Hospital NHS Trust, Nuneaton.
- Consultant Urologist and CCIO (AI and Research), Department of Clinical Informatics and Urology, George Eliot Hospital NHS Trust, Nuneaton.
- Consultant Urologist, Department of Urology, Wye Valley NHS Trust.
Abstract
Prostate cancer remains the most common cancer diagnosed in men in the UK. The adoption of pre-biopsy multiparametric MRI (mpMRI) has improved diagnostic stratification, although it has concurrently increased the burden on radiology services. Artificial intelligence (AI) systems for analysing prostate MRIs have demonstrated significant potential in validation tests. Integrating these systems into the NHS will be exceedingly challenging because of concerns around governance, safety, and workflow. This article provides a perspective on AI-assisted prostate MRI and draws on practical experience from pathway design and early implementation planning in a local general hospital. The emphasis is on governance-centric deployment, human-in-the-loop safety, and pathway-level integration rather than the algorithm's performance. AI may support prostate MRI interpretation and improve efficiency within diagnostic pathways; nevertheless, its clinical efficacy is contingent on the quality of its application, rather than only on its validation. Governance-driven pathway design centred on individuals is crucial for ensuring that AI technologies enhance healthcare practices while maintaining safety, equity, and professional autonomy.